Global MRSA Antibiotic Preparations Market Research Report 2023

Publication ID:

PB504237184

Publication Date:

May 16, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE) are specific, antibiotic-resistant bacteria that spread by contact and can cause serious infections.
Highlights
The global MRSA Antibiotic Preparations market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for MRSA Antibiotic Preparations is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for MRSA Antibiotic Preparations is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of MRSA Antibiotic Preparations include Pfizer, Lilly, Sanofi Aventis, Merck, Fresenius Kabi, Xellia Pharmaceuticals (Novo Holdings), Zhejiang Medicine, Zhejiang Hisun Pharmaceutical and North China Pharmaceutical, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for MRSA Antibiotic Preparations, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding MRSA Antibiotic Preparations.
The MRSA Antibiotic Preparations market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global MRSA Antibiotic Preparations market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the MRSA Antibiotic Preparations manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Pfizer
Lilly
Sanofi Aventis
Merck
Fresenius Kabi
Xellia Pharmaceuticals (Novo Holdings)
Zhejiang Medicine
Zhejiang Hisun Pharmaceutical
North China Pharmaceutical
Segment by Type
Vancomycin
Teicoplanin
Linezolid
Daptomycin
Others
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of MRSA Antibiotic Preparations manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of MRSA Antibiotic Preparations in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 MRSA Antibiotic Preparations Market Overview
1.1 Product Overview and Scope of MRSA Antibiotic Preparations
1.2 MRSA Antibiotic Preparations Segment by Type
1.2.1 Global MRSA Antibiotic Preparations Market Value Comparison by Type (2023-2029)
1.2.2 Vancomycin
1.2.3 Teicoplanin
1.2.4 Linezolid
1.2.5 Daptomycin
1.2.6 Others
1.3 MRSA Antibiotic Preparations Segment by Application
1.3.1 Global MRSA Antibiotic Preparations Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global MRSA Antibiotic Preparations Market Size Estimates and Forecasts
1.4.1 Global MRSA Antibiotic Preparations Revenue 2018-2029
1.4.2 Global MRSA Antibiotic Preparations Sales 2018-2029
1.4.3 Global MRSA Antibiotic Preparations Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 MRSA Antibiotic Preparations Market Competition by Manufacturers
2.1 Global MRSA Antibiotic Preparations Sales Market Share by Manufacturers (2018-2023)
2.2 Global MRSA Antibiotic Preparations Revenue Market Share by Manufacturers (2018-2023)
2.3 Global MRSA Antibiotic Preparations Average Price by Manufacturers (2018-2023)
2.4 Global MRSA Antibiotic Preparations Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of MRSA Antibiotic Preparations, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of MRSA Antibiotic Preparations, Product Type & Application
2.7 MRSA Antibiotic Preparations Market Competitive Situation and Trends
2.7.1 MRSA Antibiotic Preparations Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest MRSA Antibiotic Preparations Players Market Share by Revenue
2.7.3 Global MRSA Antibiotic Preparations Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 MRSA Antibiotic Preparations Retrospective Market Scenario by Region
3.1 Global MRSA Antibiotic Preparations Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global MRSA Antibiotic Preparations Global MRSA Antibiotic Preparations Sales by Region: 2018-2029
3.2.1 Global MRSA Antibiotic Preparations Sales by Region: 2018-2023
3.2.2 Global MRSA Antibiotic Preparations Sales by Region: 2024-2029
3.3 Global MRSA Antibiotic Preparations Global MRSA Antibiotic Preparations Revenue by Region: 2018-2029
3.3.1 Global MRSA Antibiotic Preparations Revenue by Region: 2018-2023
3.3.2 Global MRSA Antibiotic Preparations Revenue by Region: 2024-2029
3.4 North America MRSA Antibiotic Preparations Market Facts & Figures by Country
3.4.1 North America MRSA Antibiotic Preparations Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America MRSA Antibiotic Preparations Sales by Country (2018-2029)
3.4.3 North America MRSA Antibiotic Preparations Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe MRSA Antibiotic Preparations Market Facts & Figures by Country
3.5.1 Europe MRSA Antibiotic Preparations Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe MRSA Antibiotic Preparations Sales by Country (2018-2029)
3.5.3 Europe MRSA Antibiotic Preparations Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific MRSA Antibiotic Preparations Market Facts & Figures by Country
3.6.1 Asia Pacific MRSA Antibiotic Preparations Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific MRSA Antibiotic Preparations Sales by Country (2018-2029)
3.6.3 Asia Pacific MRSA Antibiotic Preparations Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America MRSA Antibiotic Preparations Market Facts & Figures by Country
3.7.1 Latin America MRSA Antibiotic Preparations Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America MRSA Antibiotic Preparations Sales by Country (2018-2029)
3.7.3 Latin America MRSA Antibiotic Preparations Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa MRSA Antibiotic Preparations Market Facts & Figures by Country
3.8.1 Middle East and Africa MRSA Antibiotic Preparations Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa MRSA Antibiotic Preparations Sales by Country (2018-2029)
3.8.3 Middle East and Africa MRSA Antibiotic Preparations Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global MRSA Antibiotic Preparations Sales by Type (2018-2029)
4.1.1 Global MRSA Antibiotic Preparations Sales by Type (2018-2023)
4.1.2 Global MRSA Antibiotic Preparations Sales by Type (2024-2029)
4.1.3 Global MRSA Antibiotic Preparations Sales Market Share by Type (2018-2029)
4.2 Global MRSA Antibiotic Preparations Revenue by Type (2018-2029)
4.2.1 Global MRSA Antibiotic Preparations Revenue by Type (2018-2023)
4.2.2 Global MRSA Antibiotic Preparations Revenue by Type (2024-2029)
4.2.3 Global MRSA Antibiotic Preparations Revenue Market Share by Type (2018-2029)
4.3 Global MRSA Antibiotic Preparations Price by Type (2018-2029)
5 Segment by Application
5.1 Global MRSA Antibiotic Preparations Sales by Application (2018-2029)
5.1.1 Global MRSA Antibiotic Preparations Sales by Application (2018-2023)
5.1.2 Global MRSA Antibiotic Preparations Sales by Application (2024-2029)
5.1.3 Global MRSA Antibiotic Preparations Sales Market Share by Application (2018-2029)
5.2 Global MRSA Antibiotic Preparations Revenue by Application (2018-2029)
5.2.1 Global MRSA Antibiotic Preparations Revenue by Application (2018-2023)
5.2.2 Global MRSA Antibiotic Preparations Revenue by Application (2024-2029)
5.2.3 Global MRSA Antibiotic Preparations Revenue Market Share by Application (2018-2029)
5.3 Global MRSA Antibiotic Preparations Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer MRSA Antibiotic Preparations Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer MRSA Antibiotic Preparations Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Lilly
6.2.1 Lilly Corporation Information
6.2.2 Lilly Description and Business Overview
6.2.3 Lilly MRSA Antibiotic Preparations Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Lilly MRSA Antibiotic Preparations Product Portfolio
6.2.5 Lilly Recent Developments/Updates
6.3 Sanofi Aventis
6.3.1 Sanofi Aventis Corporation Information
6.3.2 Sanofi Aventis Description and Business Overview
6.3.3 Sanofi Aventis MRSA Antibiotic Preparations Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sanofi Aventis MRSA Antibiotic Preparations Product Portfolio
6.3.5 Sanofi Aventis Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck MRSA Antibiotic Preparations Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Merck MRSA Antibiotic Preparations Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Fresenius Kabi
6.5.1 Fresenius Kabi Corporation Information
6.5.2 Fresenius Kabi Description and Business Overview
6.5.3 Fresenius Kabi MRSA Antibiotic Preparations Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Fresenius Kabi MRSA Antibiotic Preparations Product Portfolio
6.5.5 Fresenius Kabi Recent Developments/Updates
6.6 Xellia Pharmaceuticals (Novo Holdings)
6.6.1 Xellia Pharmaceuticals (Novo Holdings) Corporation Information
6.6.2 Xellia Pharmaceuticals (Novo Holdings) Description and Business Overview
6.6.3 Xellia Pharmaceuticals (Novo Holdings) MRSA Antibiotic Preparations Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Xellia Pharmaceuticals (Novo Holdings) MRSA Antibiotic Preparations Product Portfolio
6.6.5 Xellia Pharmaceuticals (Novo Holdings) Recent Developments/Updates
6.7 Zhejiang Medicine
6.6.1 Zhejiang Medicine Corporation Information
6.6.2 Zhejiang Medicine Description and Business Overview
6.6.3 Zhejiang Medicine MRSA Antibiotic Preparations Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Zhejiang Medicine MRSA Antibiotic Preparations Product Portfolio
6.7.5 Zhejiang Medicine Recent Developments/Updates
6.8 Zhejiang Hisun Pharmaceutical
6.8.1 Zhejiang Hisun Pharmaceutical Corporation Information
6.8.2 Zhejiang Hisun Pharmaceutical Description and Business Overview
6.8.3 Zhejiang Hisun Pharmaceutical MRSA Antibiotic Preparations Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Zhejiang Hisun Pharmaceutical MRSA Antibiotic Preparations Product Portfolio
6.8.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates
6.9 North China Pharmaceutical
6.9.1 North China Pharmaceutical Corporation Information
6.9.2 North China Pharmaceutical Description and Business Overview
6.9.3 North China Pharmaceutical MRSA Antibiotic Preparations Sales, Revenue and Gross Margin (2018-2023)
6.9.4 North China Pharmaceutical MRSA Antibiotic Preparations Product Portfolio
6.9.5 North China Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 MRSA Antibiotic Preparations Industry Chain Analysis
7.2 MRSA Antibiotic Preparations Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 MRSA Antibiotic Preparations Production Mode & Process
7.4 MRSA Antibiotic Preparations Sales and Marketing
7.4.1 MRSA Antibiotic Preparations Sales Channels
7.4.2 MRSA Antibiotic Preparations Distributors
7.5 MRSA Antibiotic Preparations Customers
8 MRSA Antibiotic Preparations Market Dynamics
8.1 MRSA Antibiotic Preparations Industry Trends
8.2 MRSA Antibiotic Preparations Market Drivers
8.3 MRSA Antibiotic Preparations Market Challenges
8.4 MRSA Antibiotic Preparations Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Pfizer
Lilly
Sanofi Aventis
Merck
Fresenius Kabi
Xellia Pharmaceuticals (Novo Holdings)
Zhejiang Medicine
Zhejiang Hisun Pharmaceutical
North China Pharmaceutical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂